Marko Skrtic, Ph.D. - Publications

Affiliations: 
2012 Medical Science University of Toronto, Toronto, ON, Canada 
Area:
Oncology, Molecular Biology, Cell Biology

13 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Sriskanthadevan S, Jeyaraju DV, Chung TE, Prabha S, Xu W, Skrtic M, Jhas B, Hurren R, Gronda M, Wang X, Jitkova Y, Sukhai MA, Lin FH, Maclean N, Laister R, et al. AML cells have low spare reserve capacity in their respiratory chain that renders them susceptible to oxidative metabolic stress. Blood. 125: 2120-30. PMID 25631767 DOI: 10.1182/Blood-2014-08-594408  0.627
2013 Jhas B, Sriskanthadevan S, Skrtic M, Sukhai MA, Voisin V, Jitkova Y, Gronda M, Hurren R, Laister RC, Bader GD, Minden MD, Schimmer AD. Metabolic adaptation to chronic inhibition of mitochondrial protein synthesis in acute myeloid leukemia cells. Plos One. 8: e58367. PMID 23520503 DOI: 10.1371/Journal.Pone.0058367  0.683
2013 Sukhai MA, Prabha S, Hurren R, Rutledge AC, Lee AY, Sriskanthadevan S, Sun H, Wang X, Skrtic M, Seneviratne A, Cusimano M, Jhas B, Gronda M, MacLean N, Cho EE, et al. Lysosomal disruption preferentially targets acute myeloid leukemia cells and progenitors Journal of Clinical Investigation. 123: 315-328. PMID 23202731 DOI: 10.1172/Jci64180  0.673
2012 Schimmer AD, Skrtić M. Therapeutic potential of mitochondrial translation inhibition for treatment of acute myeloid leukemia. Expert Review of Hematology. 5: 117-9. PMID 22475277 DOI: 10.1586/Ehm.12.8  0.574
2012 Sriskanthadevan S, Chung TE, Skrtic M, Jhas B, Hurren R, Gronda M, Wang XM, Jitkova Y, Sukhai MA, Lin F, Maclean N, Laister RC, Mullen P, Xie S, Penn L, et al. AML Cells Have Altered Mitochondrial Biogenesis and Low Spare Reserve Capacity in Their Respiratory Chain That Renders Them Susceptible to Oxidative Metabolic Stress. Blood. 120: 2581-2581. DOI: 10.1182/Blood.V120.21.2581.2581  0.68
2012 Bozhena J, Sriskanthadevan S, Skrtic M, Sukhai MA, Voisin V, Jitkova Y, Gronda M, Hurren R, Wang X, Laister RC, Bader GD, Minden MD, Schimmer AD. Chronic Inhibition of Mitochondrial Translation Alters Metabolism and Stemness in AML Blood. 120: 1364-1364. DOI: 10.1182/Blood.V120.21.1364.1364  0.678
2012 Sriskanthadevan S, Skrtic M, Jhas B, Jitkova Y, Hurren R, Gronda M, Wang X, Sukhai MA, Minden M, Schimmer A. Abstract 1123: AML cells have low reserve capacity in their respiratory chain complexes leading to increased sensitivity to palmitate-induced cell death Cancer Research. 72: 1123-1123. DOI: 10.1158/1538-7445.Am2012-1123  0.675
2011 Sukhai MA, Hurren R, Rutledge A, Livak B, Wang X, Seneviratne A, Cusimano MC, Gebbia M, Skrtic M, Sun H, Gronda M, Spagnuolo PA, Urbanus M, Eppert K, Dissanayake D, et al. Lysosomal Disruption Selectively Targets Leukemia Cells and Leukemia Stem Cells Through A Mechanism Related to Increased Reactive Oxygen Species Production Blood. 118: 61-61. DOI: 10.1182/Blood.V118.21.61.61  0.688
2011 Skrtic M, Sriskanthadevan S, Livak B, Gebbia M, Wang X, Wang Z, Hurren R, Jitkova Y, Gronda M, Maclean N, Lai C, Eberhard Y, Bartoszko J, Spagnuolo PA, Rutledge A, et al. Inhibition of Mitochondrial Translation As a Therapeutic Strategy for Acute Myeloid Leukemia (AML) Blood. 118: 233-233. DOI: 10.1182/Blood.V118.21.233.233  0.692
2010 Sharmeen S, Skrtic M, Sukhai MA, Hurren R, Gronda M, Wang X, Fonseca SB, Sun H, Wood TE, Ward R, Minden MD, Batey RA, Datti A, Wrana J, Kelley SO, et al. The antiparasitic agent ivermectin induces chloride-dependent membrane hyperpolarization and cell death in leukemia cells. Blood. 116: 3593-603. PMID 20644115 DOI: 10.1182/Blood-2010-01-262675  0.659
2010 Xu GW, Ali M, Wood TE, Wong D, Maclean N, Wang X, Gronda M, Skrtic M, Li X, Hurren R, Mao X, Venkatesan M, Beheshti Zavareh R, Ketela T, Reed JC, et al. The ubiquitin-activating enzyme E1 as a therapeutic target for the treatment of leukemia and multiple myeloma. Blood. 115: 2251-9. PMID 20075161 DOI: 10.1182/Blood-2009-07-231191  0.574
2010 Skrtic M, Spagnuolo P, Wang X, Gronda M, Hurren R, Simpson CD, Fonseca S, Datti A, Wang JCY, Dick JE, Wrana JL, Kelley SO, Schimmer AD. Abstract 4538: Inhibition of mitochondrial protein synthesis with antimicrobial tigecycline preferentially induces cell death in leukemia cells Cancer Research. 70: 4538-4538. DOI: 10.1158/1538-7445.Am10-4538  0.644
2009 Sharmeen S, Skrtic M, Sukhai M, Sun J, Hurren R, Gronda M, Wang X, Wood TE, Batey RA, Fonesca S, Kelley S, Datti A, Wrana J, Schimmer AD. Activation of Chloride Channels with the Anti-Parasitic Agent Ivermectin Induces Membrane Hyperpolarization and Cell Death in Leukemia Cells. Blood. 114: 410-410. DOI: 10.1182/Blood.V114.22.410.410  0.657
Show low-probability matches.